EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 104 filers reported holding EPIZYME INC in Q1 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,810,000 | +51.5% | 207,760 | +179.3% | 0.01% | 0.0% |
| Q2 2020 | $1,195,000 | +101.5% | 74,397 | +94.6% | 0.01% | +33.3% |
| Q1 2020 | $593,000 | -87.5% | 38,239 | -90.0% | 0.01% | -72.7% |
| Q1 2019 | $4,752,000 | +32.6% | 383,348 | -34.1% | 0.02% | -40.5% |
| Q4 2018 | $3,585,000 | -46.8% | 582,103 | -8.5% | 0.04% | +27.6% |
| Q3 2018 | $6,742,000 | +487.3% | 636,102 | +883.9% | 0.03% | -39.6% |
| Q1 2018 | $1,148,000 | -33.3% | 64,651 | -51.6% | 0.05% | +128.6% |
| Q3 2015 | $1,720,000 | +43.5% | 133,714 | +167.5% | 0.02% | +31.2% |
| Q2 2015 | $1,199,000 | +79.2% | 49,979 | +40.1% | 0.02% | +77.8% |
| Q1 2015 | $669,000 | -5.2% | 35,665 | +36.9% | 0.01% | -10.0% |
| Q3 2014 | $706,000 | +167.4% | 26,059 | +207.2% | 0.01% | +150.0% |
| Q2 2014 | $264,000 | – | 8,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |